BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 36457846)

  • 21. N6-methyladenosine RNA methylation regulators contribute to the progression of prostate cancer.
    Wu Q; Xie X; Huang Y; Meng S; Li Y; Wang H; Hu Y
    J Cancer; 2021; 12(3):682-692. PubMed ID: 33403026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. m
    Chen Y; Wang J; Xu D; Xiang Z; Ding J; Yang X; Li D; Han X
    Autophagy; 2021 Feb; 17(2):457-475. PubMed ID: 31983283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive analysis of m6A regulators prognostic value in prostate cancer.
    Ji G; Huang C; He S; Gong Y; Song G; Li X; Zhou L
    Aging (Albany NY); 2020 Jul; 12(14):14863-14884. PubMed ID: 32710725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
    Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B
    J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
    Zhang Y; Liu X; Liu L; Li J; Hu Q; Sun R
    Med Sci Monit; 2020 Feb; 26():e919644. PubMed ID: 32086933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of M6A Reader HNRNPA2B1 Associated with Poor Prognosis and Tumor Progression in Lung Adenocarcinoma.
    Wang W; Li S
    Recent Pat Anticancer Drug Discov; 2023 Oct; ():. PubMed ID: 37877146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NME6 as a potential biomarker and therapeutic target involved in immune infiltration for lung adenocarcinoma.
    Luo L; Li Y; Zhang L; Yang L
    Technol Health Care; 2024 Feb; ():. PubMed ID: 38517815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis.
    Zhao Z; Cai Q; Zhang P; He B; Peng X; Tu G; Peng W; Wang L; Yu F; Wang X
    Front Mol Biosci; 2021; 8():657087. PubMed ID: 34179079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA epigenetic modification: N6-methyladenosine.
    Zhang X; Jia GF
    Yi Chuan; 2016 Apr; 38(4):275-88. PubMed ID: 27103452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N6-methyladenosine-regulated ADIRF impairs lung adenocarcinoma metastasis and serves as a potential prognostic biomarker.
    Teng Y; Zhao X; Xi Y; Fu N
    Cancer Biol Ther; 2023 Dec; 24(1):2249173. PubMed ID: 37700507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
    Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
    Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pan-Cancer Prognostic, Immunity, Stemness, and Anticancer Drug Sensitivity Characterization of N6-Methyladenosine RNA Modification Regulators in Human Cancers.
    Li R; Yin YH; Ji XL; Liu X; Li JP; Qu YQ
    Front Mol Biosci; 2021; 8():644620. PubMed ID: 34150845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic and transcriptomic alterations in m6A regulatory genes are associated with tumorigenesis and poor prognosis in head and neck squamous cell carcinoma.
    Paramasivam A; George R; Priyadharsini JV
    Am J Cancer Res; 2021; 11(7):3688-3697. PubMed ID: 34354868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ALKBH5 Modulates Asthma Progression by Downregulating N6-methyladenosine Methylation.
    Fan X; Wei C; Han Y
    Iran J Allergy Asthma Immunol; 2024 Apr; 23(2):211-219. PubMed ID: 38822515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of N
    Lu Z; Ma Y; Li Q; Liu E; Jin M; Zhang L; Wei C
    Cell Stress Chaperones; 2019 Mar; 24(2):333-342. PubMed ID: 30701478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. METTL3 Reduces Oxidative Stress-induced Apoptosis in Presbycusis by Regulating the N6-methyladenosine Level of SIRT1 mRNA.
    Wang E; Li Y; Li H; Liu Y; Ming R; Wei J; Du P; Li X; Zong S; Xiao H
    Neuroscience; 2023 Jun; 521():110-122. PubMed ID: 37087022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA N6-methyladenosine reader IGF2BP3 interacts with MYCN and facilitates neuroblastoma cell proliferation.
    Zhu K; Gao T; Wang Z; Zhang L; Tan K; Lv Z
    Cell Death Discov; 2023 May; 9(1):151. PubMed ID: 37156775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of HPCAL1 as a specific autophagy receptor involved in ferroptosis.
    Chen X; Song X; Li J; Zhang R; Yu C; Zhou Z; Liu J; Liao S; Klionsky DJ; Kroemer G; Liu J; Tang D; Kang R
    Autophagy; 2023 Jan; 19(1):54-74. PubMed ID: 35403545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma.
    Zhang X; Yu K; Ma L; Qian Z; Tian X; Miao Y; Niu Y; Xu X; Guo S; Yang Y; Wang Z; Xue X; Gu C; Fang W; Sun J; Yu Y; Wang J
    Theranostics; 2021; 11(12):5650-5674. PubMed ID: 33897873
    [No Abstract]   [Full Text] [Related]  

  • 40. WTAP-mediated N6-methyladenine Modification of circEEF2 Promotes Lung Adenocarcinoma Tumorigenesis by Stabilizing CANT1 in an IGF2BP2-dependent Manner.
    Zheng H; Cao Z; Lv Y; Cai X
    Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38619801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.